Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts.
D000917:Antibody Formation; D000961:Antilymphocyte Serum / Q000009:adverse effects; D004342:Drug Hypersensitivity; D006386:Hemagglutination Tests; D006801:Humans; D007106:Immune Sera / Q000009:adverse effects*; D005779:Immunodiffusion; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000276:immunology*; D012882:Skin Tests; D014184:Transplantation, Homologous; D005719:gamma-Globulins / Q000009:adverse effects*
D000961:Antilymphocyte Serum; D007106:Immune Sera; D007166:Immunosuppressive Agents; D005719:gamma-Globulins